Nuveen AMT-Free Municipal Credit Income Fund
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVG research report →
Price Chart
About the company
Nuveen AMT-Free Municipal Credit Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States.
- IPO
- 2002
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on NVG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.65B
- P/E
- 13.62
- PEG
- 0.04
- P/S
- 11.51
- P/B
- 0.97
- EV/EBITDA
- 17.84
- Div Yield
- 7.73%
- Gross Margin
- 75.38%
- Op Margin
- 111.51%
- Net Margin
- 83.28%
- ROE
- 6.99%
- ROIC
- 5.45%
Latest fiscal year · YoY change
- Revenue
- $215.14M-13.6%
- Gross Profit
- $185.75M-15.0%
- Op Income
- $127.41M
- Net Income
- $57.03M-89.7%
- EPS
- $0.27-89.6%
- OCF Growth
- +5.2%
- FCF Growth
- +5.2%
- 52W High
- $13.59
- 52W Low
- $11.59
- 50D MA
- $12.58
- 200D MA
- $12.66
- Beta
- 0.79
- RSI (14)
- 37
- Avg Volume
- 481.78K
No earnings-call transcripts are available for NVG yet.
- Free Float
- 100.0%
- Shares Outstanding
- 215.82M
- Float Shares
- 215.82M
of shares held by institutions
255 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Guggenheim Capital LLC | 3.12M | ▲ 162.64K |
| Morgan Stanley | 2.72M | ▼ 10.59K |
| Hennion & Walsh Asset Management, Inc. | 2.21M | ▲ 292.52K |
| Wells Fargo & Company/Mn | 1.54M | ▲ 75.45K |
| Ubs Group AG | 1.43M | ▼ 539.17K |
| Bank Of America Corp | 1.42M | ▲ 157.11K |
| Raymond James Financial Inc | 1.39M | ▲ 150.08K |
| Van Eck Associates Corp | 1.05M | ▲ 35.31K |
| Lpl Financial LLC | 1.05M | ▼ 44.90K |
| Advisors Asset Management, Inc. | 675.08K | ▼ 10.97K |
| Cornerstone Advisory, LLC | 619.79K | ▼ 16.68K |
| Congress Park Capital LLC | 598.00K | ▲ 15.00K |
Held by 78 ETFs
Biggest fund positions in NVG by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 10, 26 | BRENNAN PAUL L | sell | 1,000 |
| Aug 10, 26 | BRENNAN PAUL L | sell | 2,000 |
| Aug 10, 26 | BRENNAN PAUL L | sell | 2,000 |
| Oct 16, 25 | Castro Joseph | other | 0 |
| Oct 16, 25 | Page Robert Tanner | other | 0 |
| Dec 2, 24 | Cardella Marc | other | 0 |
| Nov 6, 24 | LAMB DAVID J | buy | 3,000 |
| Feb 28, 24 | Ramsay Mary Beth | other | 0 |
| Feb 28, 24 | Nelson James N III | other | 0 |
| Jan 1, 24 | STARR LOREN M | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NVG coverage
Recent articles, reports, and earnings notes.
No research on NVG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NVG report →NervGen Pharma: I Think The Biggest Risks Are Now Behind It
seekingalpha.com · Jul 2
A Pair Trade Opportunity By Nuveen Municipal Credit Income Funds
seekingalpha.com · Jun 22
NVG: Flirting With A Premium Limits Current Appeal
seekingalpha.com · Jun 2
NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study
globenewswire.com · May 26
Vision Marine Technologies Accelerates Operational Transformation with NVG Segment Near EBITDA Breakeven and Significant Balance Sheet Improvements
prnewswire.com · Apr 15
NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia
globenewswire.com · Apr 7
RiverNorth Capital Trims Position in Nuveen AMT-Free Municipal Credit Income Fund
fool.com · Mar 13
NVG Vs. NZF: Comparing Nuveen Munis I Hold
seekingalpha.com · Feb 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.